"Cushing's disease of the omentum" - Fat or fiction?

Journal of Endocrinological Investigation

Volumn 27, Issue 2, 2004, Pages 171-174

  Tomlinson, J W ^a   Stewart, P M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

11 hydroxysteroid dehydrogenase; Adipose tissue; Cortisol; Obesity

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA(OR 20BETA) HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE;

ADIPOCYTE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CUSHING SYNDROME; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE OVEREXPRESSION; HUMAN; HYDROCORTISONE RELEASE; IN SITU HYBRIDIZATION; IN VITRO STUDY; NONHUMAN; OBESITY;

EID: 1942520410     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346264     Document Type: Article

References (18)

1. Tomlinson JW, Stewart PM. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase. Best Pract Res Clin Endocrinol Metab 2001, 15: 61-78.
2. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum"? Lancet 1997, 349: 1210-3.
3. Hauner H, Schmid P, Pfeiffer EF. Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab 1987, 64: 832-5.
4. Bujalska IJ, Kumar S, Hewison M, Stewart PM. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology 1999, 140: 3188-96.
5. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294: 2166-70.
6. Livingstone DE, Jones GC, Smith K, et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000, 141: 560-3.
7. Morton NM, Patterson JM, Holmes MC, Walker BR, Mullins JJ, Seckl JR. 11 beta-Hydroxysteroid Dehydrogeanse Type 1 Null Mice Resist Dietary Obesity and its Metabolic Consequences. Proceedings of the 84th annual meeting of the Endocrine Society, San Francisco, CA, 2002, OR17-3. (Abstract).
8. Morton NM, Patterson JM, Masuzaki H, et al. Reduced intra-adipose glucocorticoid regeneration: A novel adaptive response to, and therapy for, the metabolic syndrome. Endocrine Abstracts 2003, 5: S23. (Abstract)
9. Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH. Cortisol metabolism in human obesity: impaired cortisone→cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 1999, 84: 1022-7.
10. Rask E, Olsson T, Soderberg S, et al. Tissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity. J Clin Endocrinol Metab 2001, 86: 1418-21.
11. Weidenfeld J, Siegel RA, Levy J, Chowers I. In vitro metabolism of cortisol by human abdominal adipose tissue. J Steroid Biochem 1982, 17: 357-60.
12. Rask E, Walker BR, Soderberg S, et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002, 87: 3330-6.
13. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M. Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab 2002, 87: 2701-5.
14. Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM. Expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab 2002, 87: 5630-5.
15. Jamieson A, Wallace AM, Andrew R, et al. Apparent cortisone reductase deficiency: a functional defect in 11β-hydroxysteroid dehydrogenase type 1. J Clin Endocrinol Metab 1999, 84: 3570-4.
16. Laing I, Adams JE, Wood PJ, Taylor NF, Ray DW. Cortisone reductase deficiency (11β-hydroxysteroid dehydrogenase type 1) deficiency presenting with features of late onset congenital adrenal hyperplasia. Endocrine Abstracts 2002, 3: P264. (Abstract)
17. Alberts P, Engblom L, Edling N, et al. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 2002, 45: 1528-32.
18. Katz JR, Mohamed-Ali V, Wood PJ, Yudkin JS, Coppack SW. An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin Endocrinol (Oxf) 1999, 50: 63-8.